
HQ - Cambridge, MA
Summary
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
Senior Management
Martin Huber
President and Chief Executive Officer